Diamond-Blackfan Anemia (DBA)

Childhood Cancer Clinical Trials

Find answers to common questions about clinical trials for childhood cancer, including whether or not a clinical trial may be the right choice for your child. Contact us and we can help you navigate your options.

Clinical Trials for Pediatric Patients

What Is Diamond-Blackfan Anemia?

Diamond-Blackfan anemia (DBA) is a rare blood disorder that occurs when the bone marrow fails to make red blood cells, which are essential for carrying oxygen from the lungs to all the other parts of the body. It is a type of bone marrow failure.

DBA Treatment at Dana-Farber/Boston Children's

Children and teens with Diamond-Blackfan anemia (DBA) are treated by our team of experts at Dana-Farber/Boston Children's Cancer and Blood Disorders Center through our Bone Marrow Failure and Myelodysplastic Syndrome Program, recognized as one of the nation’s best pediatric treatment and research programs for bone marrow failure and related conditions. Our patients have access to advanced treatments and diagnosis, including DNA mutation identification and ongoing clinical trials investigating new treatments. Dana-Farber/Boston Children's is also home to one of the largest and most experienced pediatric stem cell transplant centers in the world. Stem cell (bone marrow) transplant is currently the only cure for DBA.

Learn More

Find more in-depth information on Diamond-Blackfan anemia on the Boston Children's Hospital website, including answers to:

  • What causes Diamond-Blackfan anemia?
  • What are the symptoms of Diamond-Blackfan anemia?
  • How is Diamond-Blackfan anemia diagnosed?
  • How is Diamond-Blackfan anemia treated?
  • What is the latest research on Diamond-Blackfan anemia?